GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
WGS is expected to report earnings to fall 71.20% to 14 cents per share on March 17
Q4'25
Est.
$0.14
Q3'25
Beat
by $0.08
Q2'25
Beat
by $0.38
Q1'25
Missed
by $0.29
Q4'24
Beat
by $0.56
The last earnings report on October 28 showed earnings per share of 49 cents, beating the estimate of 40 cents. With 253.76K shares outstanding, the current market capitalization sits at 3.94B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. WGS showed earnings on October 28, 2025. You can read more about the earnings report here.